Le Lézard
Classified in: Health
Subjects: TDS, TRI, FVT

Tandem Cycling Linked to Improved Health for Those with Parkinson's, Care Partners


MINNEAPOLIS, Feb. 29, 2024 /PRNewswire/ -- Pedaling on a stationary bicycle built for two may improve the health and well-being for both people with Parkinson's disease and their care partners, according to a small, preliminary study released February 29, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13?18, 2024, in person in Denver and online.

"Our study found that a unique cycling program that pairs people with Parkinson's disease with their care partners can improve the physical, emotional and mental well-being of both cyclists to improve their quality of life," said Jennifer Trilk, PhD, of the University of South Carolina School of Medicine in Greenville. "It is just as important that care partners also receive care, so that is why we included them as the cycling partner. The goal of our small study was to determine if tandem cycling was beneficial. The next step will be to confirm the results with subsequent studies that would include more participants."

The study included 18 participants, nine with Parkinson's disease and their corresponding nine care partners.

For the tandem cycling program, pairs of people with Parkinson's disease and their care partners cycled on indoor, stationary tandem bicycles while using a virtual reality platform two times per week for eight weeks. During each session, all participants could visualize themselves cycling along real life, scenic outdoor routes by watching large television screens that were synced to the cycling intensity. The tandem cycling set-up also allowed the care partners to help adjust the cycling pace and facilitate a higher pedaling rate for greater health benefits.

Prior to starting the cycling program, all participants completed a series of tests. Participants repeated the same tests two days after the final cycling session eight weeks later.

For a test of resiliency, participants ranked a series of six statements regarding their perceived ability to bounce back or recover from stress. Statements were ranked on a scale of one to five, with higher numbers indicating stronger agreement. Statements included "I tend to bounce back quickly after hard times" and "I usually come through difficult times with little trouble."

While people with Parkinson's disease did not show improvements in resiliency, researchers found care partners demonstrated individual improvements in overall resiliency, which Trilk noted may help to decrease care partner burden. Care partners also demonstrated statistically significant improvements in depression scores after the cycling intervention.

Those with Parkinson's disease completed additional disease-associated tests, including a questionnaire on how often they experience difficulties in daily living, including relationships, social situations and communication. They also completed physical tests, including a test used to gauge the severity and progression of their disease as well as a walking speed test.

People with Parkinson's disease improved across their respective tests.

In the test measuring overall perception of difficulties in daily living, where higher scores indicate a lower quality of life, on a scale of zero to 100, participants decreased their total score by nearly five points, indicating improved overall quality of life. Participants with Parkinson's disease also showed significant improvements in mobility on this test, in which they had a decrease of nearly 14 points, indicating improved overall physical function.

Researchers also found that participants with Parkinson's disease had a decrease of eight points in the test gauging the overall motor severity and progression of their disease, where higher scores indicate greater disease burden. Overall scores range from zero to 132.

They also improved their walking speed, with an increase of 0.27 meters per second.

The study was supported by the Prisma Health-Upstate Office of Philanthropy and Partnership.

Learn more about Parkinson's disease at BrainandLife.org, home of the American Academy of Neurology's free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, X and Instagram.

When posting to social media channels about this research, we encourage you to use the American Academy of Neurology's Annual Meeting hashtag #AANAM.

The American Academy of Neurology is the world's largest association of neurologists and neuroscience professionals, with over 40,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, concussion, Parkinson's disease and epilepsy.

For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, X, Instagram, LinkedIn and YouTube.

SOURCE American Academy of Neurology


These press releases may also interest you

at 06:50
Pfizer Inc. highlights its progress in advancing new potential standards of care in Oncology at the 2024 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place May 31 to June 4 in Chicago. More than 50 abstracts, including 11...

at 06:30
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due...

at 06:17
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

at 06:05
Revvity, Inc. , today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as compared to $4.50 in the same period a year ago. GAAP revenue for the quarter was $650 million,...

at 06:00
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm...

at 06:00
Repertoire® Immune...



News published on and distributed by: